Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Aug 10;50(2):1701319.
doi: 10.1183/13993003.01319-2017. Print 2017 Aug.

Immune checkpoint inhibitor-associated interstitial lung diseases: some progress but still many issues

David Montani  1   2   3 , Andrei Seferian  4   2   3 , Florence Parent  4   2   3 , Marc Humbert  4   2   3
Affiliations
Free article
Editorial

Immune checkpoint inhibitor-associated interstitial lung diseases: some progress but still many issues

David Montani et al. Eur Respir J. .
Free article
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared

Comment on

  • Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients.
    Delaunay M, Cadranel J, Lusque A, Meyer N, Gounant V, Moro-Sibilot D, Michot JM, Raimbourg J, Girard N, Guisier F, Planchard D, Metivier AC, Tomasini P, Dansin E, Pérol M, Campana M, Gautschi O, Früh M, Fumet JD, Audigier-Valette C, Couraud S, Dalle S, Leccia MT, Jaffro M, Collot S, Prévot G, Milia J, Mazieres J. Delaunay M, et al. Eur Respir J. 2017 Aug 10;50(2):1700050. doi: 10.1183/13993003.00050-2017. Print 2017 Aug. Eur Respir J. 2017. PMID: 28798088 Clinical Trial.

References

    1. JAMA Oncol. 2016 Dec 1;2(12 ):1607-1616 - PubMed
    1. N Engl J Med. 2015 Jul 16;373(3):288-90 - PubMed
    1. Cancer Immunol Res. 2015 Oct;3(10 ):1185-92 - PubMed
    1. Eur Respir J. 2017 Aug 10;50(2):null - PubMed
    1. Int J Rheum Dis. 2017 May 8;:null - PubMed

Substances

LinkOut - more resources